The role of Ras signaling in lupus T lymphocytes: Biology and pathogenesis

Clinical Immunology

Volumn 125, Issue 3, 2007, Pages 215-223

  Mor, Adam ^a,b   Philips, Mark R ^a   Pillinger, Michael H ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

CAPRI; Erk; Farnesylation; PI 3 K; Ras; RasGRP1; Systemic lupus erythematosus; T cell receptor; T lymphocyte

Indexed keywords

RAS PROTEIN; T LYMPHOCYTE RECEPTOR;

AUTOIMMUNITY; BIOLOGY; CELL ACTIVATION; CELL FUNCTION; CELL MATURATION; CELL MEMBRANE; GOLGI COMPLEX; HUMAN; IMMUNOPATHOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN FUNCTION; SHORT SURVEY; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

ANIMALS; CELL DIFFERENTIATION; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; ONCOGENE PROTEIN P21(RAS); SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 36148952923     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2007.08.008     Document Type: Short Survey

References (74)

1. NiChoileain N., and Redmond H.P. Regulatory T-cells and autoimmunity. J. Surg. Res. 130 (2006) 124-135
2. Blanco P., Viallard J.F., Pellegrin J.L., and Moreau J.F. Cytotoxic T lymphocytes and autoimmunity. Curr. Opin. Rheumatol. 17 (2005) 731-734
3. Jiang H., and Chess L. Regulation of immune responses by T cells. N. Engl. J. Med. 354 (2006) 1166-1176
4. La Cava A., Fang C.J., Singh R.P., Ebling F., and Hahn B.H. Manipulation of immune regulation in systemic lupus erythematosus. Autoimmun. Rev. 4 (2005) 515-519
5. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., and Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155 (1995) 1151-1164
6. Millar D.G., Garza K.M., Odermatt B., Elford A.R., Ono N., Li Z., and Ohashi P.S. Hsp70 promotes antigen-presenting cell function and converts T-cell tolerance to autoimmunity in vivo. Nat. Med. 9 (2003) 1469-1476
7. Liossis S.N., Ding X.Z., Dennis G.J., and Tsokos G.C. Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain. J. Clin. Invest. 101 (1998) 1448-1457
8. Mudd P.A., Teague B.N., and Farris A.D. Regulatory T cells and systemic lupus erythematosus. Scand. J. Immunol. 64 (2006) 211-218
9. Rioux J.D., and Abbas A.K. Paths to understanding the genetic basis of autoimmune disease. Nature 435 (2005) 584-589
10. King P.D. Lupus-like autoimmunity caused by defects in T-cell signal transduction. Curr. Opin. Investig. Drugs 5 (2004) 517-523
11. Layer K., Lin G., Nencioni A., Hu W., Schmucker A., Antov A.N., Li X., Takamatsu S., Chevassut T., Dower N.A., Stang S.L., Beier D., Buhlmann J., Bronson R.T., Elkon K.B., Stone J.C., Van Parijs L., and Lim B. Autoimmunity as the consequence of a spontaneous mutation in Rasgrp1. Immunity 19 (2003) 243-255
12. Chen Y.F., and Morel L. Genetics of T cell defects in lupus. Cell Mol. Immunol. 2 (2005) 403-409
13. Drappa J., Kamen L.A., Chan E., Georgiev M., Ashany D., Marti F., and King P.D. Impaired T cell death and lupus-like autoimmunity in T cell-specific adapter protein-deficient mice. J. Exp. Med. 198 (2003) 809-821
14. Xue C., Lan-Lan W., Bei C., Jie C., and Wei-Hua F. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus. Cell. Immunol. 239 (2006) 121-128
15. Marti F., Garcia G.G., Lapinski P.E., MacGregor J.N., and King P.D. Essential role of the T cell-specific adapter protein in the activation of LCK in peripheral T cells. J. Exp. Med. 203 (2006) 281-287
16. Perez de Castro I., Bivona T.G., Philips M.R., and Pellicer A. Ras activation in Jurkat T cells following low-grade stimulation of the T-cell receptor is specific to N-Ras and occurs only on the Golgi apparatus. Mol. Cell Biol. 24 (2004) 3485-3496
17. Philips M.R. Compartmentalized signalling of Ras. Biochem. Soc. Trans. 33 (2005) 657-661
18. Quilliam L.A., Rebhun J.F., and Castro A.F. A growing family of guanine nucleotide exchange factors is responsible for activation of Ras-family GTPases. Prog. Nucleic Acid Res. Mol. Biol. 71 (2002) 391-444
19. Bollag G., and McCormick F. Differential regulation of rasGAP and neurofibromatosis gene product activities. Nature 351 (1991) 576-579
20. Mor A., and Philips M.R. Compartmentalized Ras/MAPK Signaling. Annu. Rev. Immunol. 24 (2006) 771-800
21. Chiu V.K., Bivona T., Hach A., Sajous J.B., Silletti J., Wiener H., Johnson R.L., Cox A.D., and Philips M.R. Ras signalling on the endoplasmic reticulum and the Golgi. Nat. Cell Biol. 4 (2002) 343-350
22. Quatela S.E., and Philips M.R. Ras signaling on the Golgi. Curr. Opin. Cell Biol. 18 (2006) 162-167
23. Wright L.P., and Philips M.R. Thematic review series: lipid posttranslational modifications. CAAX modification and membrane targeting of Ras. J. Lipid Res. 47 (2006) 883-891
24. Chiu V.K., Silletti J., Dinsell V., Wiener H., Loukeris K., Ou G., Philips M.R., and Pillinger M.H. Carboxyl methylation of Ras regulates membrane targeting and effector engagement. J. Biol. Chem. 279 (2004) 7346-7352
25. Cantrell D.A. GTPases and T cell activation. Immunol. Rev. 192 (2003) 122-130
26. Stone J.C. Regulation of Ras in lymphocytes: get a GRP. Biochem. Soc. Trans. 34 (2006) 858-861
27. de Castro I.P., Diaz R., Malumbres M., Hernandez M.I., Jagirdar J., Jimenez M., Ahn D., and Pellicer A. Mice deficient for N-ras: impaired antiviral immune response and T-cell function. Cancer Res. 63 (2003) 1615-1622
28. Swat W., Shinkai Y., Cheng H.L., Davidson L., and Alt F.W. Activated Ras signals differentiation and expansion of CD4+8+ thymocytes. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 4683-4687
29. Yamashita M., Shinnakasu R., Asou H., Kimura M., Hasegawa A., Hashimoto K., Hatano N., Ogata M., and Nakayama T. Ras-ERK MAPK cascade regulates GATA3 stability and Th2 differentiation through ubiquitin-proteasome pathway. J. Biol. Chem. 280 (2005) 29409-29419
30. Alberola-Ila J., and Hernandez-Hoyos G. The Ras/MAPK cascade and the control of positive selection. Immunol. Rev. 191 (2003) 79-96
31. Yamashita M., Kimura M., Kubo M., Shimizu C., Tada T., Perlmutter R.M., and Nakayama T. T cell antigen receptor-mediated activation of the Ras/mitogen-activated protein kinase pathway controls interleukin 4 receptor function and type-2 helper T cell differentiation. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 1024-1029
32. Yamashita T., and Boros D.L. IL-4 influences IL-2 production and granulomatous inflammation in murine schistosomiasis mansoni. J. Immunol. 149 (1992) 3659-3664
33. Yamashita M., Yamaoka M., Seki N., and Fujii T. Non-T cell-derived IL-4 plays an important role in IgE production induced by antigen resensitization and is resistant to FK506. J. Immunol. 157 (1996) 714-719
34. So E.Y., Oh J., Jang J.Y., Kim J.H., and Lee C.E. Ras/Erk pathway positively regulates Jak1/STAT6 activity and IL-4 gene expression in Jurkat T cells. Mol. Immunol. 44 (2007) 3416-3426
35. Shibata Y., Kamata T., Kimura M., Yamashita M., Wang C.R., Murata K., Miyazaki M., Taniguchi M., Watanabe N., and Nakayama T. Ras activation in T cells determines the development of antigen-induced airway hyperresponsiveness and eosinophilic inflammation. J. Immunol. 169 (2002) 2134-2140
36. Reedquist K.A., Ludikhuize J., and Tak P.P. Phosphoinositide 3-kinase signalling and FoxO transcription factors in rheumatoid arthritis. Biochem. Soc. Trans. 34 (2006) 727-730
37. Roose J.P., Mollenauer M., Ho M., Kurosaki T., and Weiss A. Unusual interplay of two types of Ras activators, RasGRP and SOS, establishes sensitive and robust Ras activation in lymphocytes. Mol. Cell. Biol. 27 (2007) 2732-2745
38. Hanafusa H., Torii S., Yasunaga T., and Nishida E. Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway. Nat. Cell Biol. 4 (2002) 850-858
39. Choi H., Cho S.Y., Schwartz R.H., and Choi K. Dual effects of Sprouty1 on TCR signaling depending on the differentiation state of the T cell. J. Immunol. 176 (2006) 6034-6045
40. Bivona T.G., Perez De Castro I., Ahearn I.M., Grana T.M., Chiu V.K., Lockyer P.J., Cullen P.J., Pellicer A., Cox A.D., and Philips M.R. Phospholipase Cgamma activates Ras on the Golgi apparatus by means of RasGRP1. Nature 424 (2003) 694-698
41. Mor A., Campi G., Du G., Zheng Y., Foster D.A., Dustin M.L., and Philips M.R. The lymphocyte function-associated antigen-1 receptor costimulates plasma membrane Ras via phospholipase D2. Nat. Cell Biol. 9 (2007) 713-719
42. Olenchock B.A., Guo R., Carpenter J.H., Jordan M., Topham M.K., Koretzky G.A., and Zhong X.P. Disruption of diacylglycerol metabolism impairs the induction of T cell anergy. Nat. Immunol. 7 (2006) 1174-1181
43. Roose J.P., Mollenauer M., Gupta V.A., Stone J., and Weiss A. A diacylglycerol-protein kinase C-RasGRP1 pathway directs Ras activation upon antigen receptor stimulation of T cells. Mol. Cell Biol. 25 (2005) 4426-4441
44. Cacalano N.A., Sanden D., and Johnston J.A. Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras. Nat. Cell Biol. 3 (2001) 460-465
45. Dustin M.L. Impact of the immunological synapse on T cell signaling. Results Probl. Cell Differ. 43 (2006) 175-198
46. Perez O.D., Mitchell D., Jager G.C., South S., Murriel C., McBride J., Herzenberg L.A., Kinoshita S., and Nolan G.P. Leukocyte functional antigen 1 lowers T cell activation thresholds and signaling through cytohesin-1 and Jun-activating binding protein 1. Nat. Immunol. 4 (2003) 1083-1092
47. Daniels M.A., Teixeiro E., Gill J., Hausmann B., Roubaty D., Holmberg K., Werlen G., Hollander G.A., Gascoigne N.R., and Palmer E. Thymic selection threshold defined by compartmentalization of Ras/MAPK signalling. Nature 444 (2006) 724-729
48. Li L., Godfrey W.R., Porter S.B., Ge Y., June C.H., Blazar B.R., and Boussiotis V.A. CD4+CD25+ regulatory T-cell lines from human cord blood have functional and molecular properties of T-cell anergy. Blood 106 (2005) 3068-3073
49. Rapoport M.J., Sharabi A., Aharoni D., Bloch O., Zinger H., Dayan M., and Mozes E. Amelioration of SLE-like manifestations in (NZBxNZW)F1 mice following treatment with a peptide based on the complementarity determining region 1 of an autoantibody is associated with a down-regulation of apoptosis and of the pro-apoptotic factor JNK kinase. Clin. Immunol. 117 (2005) 262-270
50. Magee A.I., Newman C.M., Giannakouros T., Hancock J.F., Fawell E., and Armstrong J. Lipid modifications and function of the ras superfamily of proteins. Biochem. Soc. Trans. 20 (1992) 497-499
51. Katzav A., Kloog Y., Korczyn A.D., Niv H., Karussis D.M., Wang N., Rabinowitz R., Blank M., Shoenfeld Y., and Chapman J. Treatment of MRL/lpr mice, a genetic autoimmune model, with the Ras inhibitor, farnesylthiosalicylate (FTS). Clin. Exp. Immunol. 126 (2001) 570-577
52. Klinman D.M., Mushinski J.F., Honda M., Ishigatsubo Y., Mountz J.D., Raveche E.S., and Steinberg A.D. Oncogene expression in autoimmune and normal peripheral blood mononuclear cells. J. Exp. Med. 163 (1986) 1292-1307
53. Deng C., Kaplan M.J., Yang J., Ray D., Zhang Z., McCune W.J., Hanash S.M., and Richardson B.C. Decreased Ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients. Arthritis Rheum. 44 (2001) 397-407
54. Abeles A.M., and Pillinger M.H. Statins as antiinflammatory and immunomodulatory agents: a future in rheumatologic therapy?. Arthritis Rheum. 54 (2006) 393-407
55. Ghittoni R., Patrussi L., Pirozzi K., Pellegrini M., Lazzerini P.E., Capecchi P.L., Pasini F.L., and Baldari C.T. Simvastatin inhibits T-cell activation by selectively impairing the function of Ras superfamily GTPases. FASEB J. 19 (2005) 605-607
56. Abud-Mendoza C., de la Fuente H., Cuevas-Orta E., Baranda L., Cruz-Rizo J., and Gonzalez-Amaro R. Therapy with statins in patients with refractory rheumatic diseases: a preliminary study. Lupus 12 (2003) 607-6011
57. Rapoport M.J., Mor A., Amit M., Rosenberg R., Ramot Y., Mizrachi A., and Wysenbeek A.J. Decreased expression of the p21ras stimulatory factor hSOS in PBMC from inactive SLE patients. Lupus 8 (1999) 24-28
58. Rapoport M.J., Amit M., Aharoni D., Weiss M., Weissgarten J., Bruck N., Buchs A., Bistritzer T., and Molad Y. Constitutive up-regulated activity of MAP kinase is associated with down-regulated early p21Ras pathway in lymphocytes of SLE patients. J. Autoimmun. 19 (2002) 63-70
59. Cedeno S., Cifarelli D.F., Blasini A.M., Paris M., Placeres F., Alonso G., and Rodriguez M.A. Defective activity of ERK-1 and ERK-2 mitogen-activated protein kinases in peripheral blood T lymphocytes from patients with systemic lupus erythematosus: potential role of altered coupling of Ras guanine nucleotide exchange factor hSos to adapter protein Grb2 in lupus T cells. Clin. Immunol. 106 (2003) 41-49
60. Norment A.M., Bogatzki L.Y., Klinger M., Ojala E.W., Bevan M.J., and Kay R.J. Transgenic expression of RasGRP1 induces the maturation of double-negative thymocytes and enhances the production of CD8 single-positive thymocytes. J. Immunol. 170 (2003) 1141-1149
61. Priatel J.J., Teh S.J., Dower N.A., Stone J.C., and Teh H.S. RasGRP1 transduces low-grade TCR signals which are critical for T cell development, homeostasis, and differentiation. Immunity 17 (2002) 617-627
62. Guilbault B., and Kay R.J. RasGRP1 sensitizes an immature B cell line to antigen receptor-induced apoptosis. J. Biol. Chem. 279 (2004) 19523-19530
63. Coughlin J.J., Stang S.L., Dower N.A., and Stone J.C. RasGRP1 and RasGRP3 regulate B cell proliferation by facilitating B cell receptor-Ras signaling. J. Immunol. 175 (2005) 7179-7184
64. Sestak A.L., Nath S.K., Sawalha A.H., and Harley J.B. Current status of lupus genetics. Arthritis Res. Ther. 9 (2007) 210
65. Deng C., Lu Q., Zhang Z., Rao T., Attwood J., Yung R., and Richardson B. Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling. Arthritis Rheum. 48 (2003) 746-756
66. Kaplan M.J., Deng C., Yang J., and Richardson B.C. DNA methylation in the regulation of T cell LFA-1 expression. Immunol. Invest. 29 (2000) 411-425
67. Toyota M., and Issa J.P. The role of DNA hypermethylation in human neoplasia. Electrophoresis 21 (2000) 329-333
68. Hickman S.P., Yang J., Thomas R.M., Wells A.D., and Turka L.A. Defective activation of protein kinase C and Ras-ERK pathways limits IL-2 production and proliferation by CD4+CD25+ regulatory T cells. J. Immunol. 177 (2006) 2186-2194
69. K. Tenbrock, Y.T. Juang, V.C. Kyttaris, G.C. Tsokos, Altered signal transduction in SLE T cells, Rheumatology (in press) (electronic publication ahead of print).
70. Hickman S.P., Yang J., Thomas R.M., Wells A.D., and Turka L.A. Defective activation of protein kinase C and Ras-ERK pathways limits IL-2 production and +CD25+ regulatory T cells. J. Immunol. 178 (2007) 1938-1947
71. Gupta S., Ramjaun A.R., Haiko P., Wang Y., Warne P.H., Nicke B., Nye E., Stamp G., Alitalo K., and Downward J. Binding of ras to phosphoinositide 3-kinase p110alpha is required for Ras-driven tumorigenesis in mice. Cell 129 (2007) 957-968
72. Barber D.F., Bartolome A., Hernandez C., Flores J.M., Redondo C., Fernandez-Arias C., Camps M., Ruckle T., Schwarz M.K., Rodriguez S., Martinez A.C., Balomenos D., Rommel C., and Carrera A.C. PI3Kgamma inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus. Nat. Med. 11 (2005) 933-935
73. Samstag Y., and Nebl G. Ras initiates phosphatidyl-inositol-3-kinase (PI3K)/PKB mediated signalling pathways in untransformed human peripheral blood T lymphocytes. Adv. Enzyme Regul. 45 (2005) 52-62
74. Li Y., Harada T., Juang Y.T., Kyttaris V.C., Wang Y., Zidanic M., Tung K., and Tsokos G.C. Phosphorylated ERM is responsible for increased T cell polarization, adhesion, and migration in patients with systemic lupus erythematosus. J. Immunol. 178 (2007) 1938-1947